AMRN : I was not surprised at all, i think people are still underestimating it! I was expecting 100 % jump. It is undervalued at these level.. .
On cc when one of the analyst, i think jefferis, asked the ceo about market , CEO said, 1 billion/year for marine indication and 10 billion/year for anchor indication . remember they have patent protection up to 2030 with soem protection up to 2021. I think it will be biggest blockbuster after statin, bigger than DNDN and HGSI.
44 million us population , rest of the world, canada, europe, japan, china, target population will be 120 million. everybody is not going to take it , but target population is huge. I am not trying to pump it because i have left over. I am trying to put the facts which CEO said in the CC today. ADD to that miniscule ireland 12 % corporate tax rate.
In biotech nothing is certain, but AMRN is as good as it can be for the medium term investor IMO .
leerink target is 25 now, canacord is 18 and some body else gave target of 21. Tomorrow, i expect some more upgrades in the morning.
